Literature DB >> 23523580

Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.

Manuela Merli1, Cristina Lucidi, Ilaria Pentassuglio, Valerio Giannelli, Michela Giusto, Vincenza Di Gregorio, Chiara Pasquale, Silvia Nardelli, Barbara Lattanzi, Mario Venditti, Oliviero Riggio.   

Abstract

BACKGROUND & AIMS: A causal relationship between infection, systemic inflammation, and hepatic encephalopathy (HE) has been suggested in cirrhosis. No study, however, has specifically examined, in cirrhotic patients with infection, the complete pattern of clinical and subclinical cognitive alterations and its reversibility after resolution. Our investigation was aimed at describing the characteristics of cognitive impairment in hospitalized cirrhotic patients, in comparison with patients without liver disease, with and without infection.
METHODS: One hundred and fifty cirrhotic patients were prospectively enrolled. Eighty-one patients without liver disease constituted the control group. Bacterial infections and sepsis were actively searched in all patients independently of their clinical evidence at entry. Neurological and psychometric assessment was performed at admission and in case of nosocomial infection. The patients were re-evaluated after the resolution of the infection and 3months later.
RESULTS: Cognitive impairment (overt or subclinical) was recorded in 42% of cirrhotics without infection, in 79% with infection without SIRS and in 90% with sepsis. The impairment was only subclinical in controls and occurred only in patients with sepsis (42%). Multivariate analysis selected infection as the only independent predictor of cognitive impairment (OR 9.5; 95% CI 3.5-26.2; p=0.00001) in cirrhosis. The subclinical alterations detected by psychometric tests were also strongly related to the infectious episode and reversible after its resolution.
CONCLUSIONS: Infections are associated with a worse cognitive impairment in cirrhotics compared to patients without liver disease. The search and treatment of infections are crucial to ameliorate both clinical and subclinical cognitive impairment of cirrhotic patients.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  C-reactive protein; CRP; DST; HE; Hepatic encephalopathy; Hyperammonemia; MHE; Minimal hepatic encephalopathy; Psycometric test; SIRS; Sepsis; Systemic inflammatory response syndrome (SIRS); TMT-A; TMT-B; digit-symbol test; hepatic encephalopathy; minimal hepatic encephalopathy; systemic inflammatory response syndrome; trail-making test A; trail-making test B

Mesh:

Year:  2013        PMID: 23523580     DOI: 10.1016/j.jhep.2013.03.012

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  15 in total

1.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

Review 2.  Clinical Consequences of Infection in Cirrhosis: Organ Failures and Acute-on-Chronic Liver Failure.

Authors:  Florence Wong
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-10-09

Review 3.  Current state of knowledge of hepatic encephalopathy (part IV): Management of Hepatic Encephalopathy by liver support systems.

Authors:  Tarek Hassanein
Journal:  Metab Brain Dis       Date:  2016-12-24       Impact factor: 3.584

4.  Expression of α-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function.

Authors:  Georgios I Tsiaoussis; Eleni C Papaioannou; Eleni P Kourea; Stelios F Assimakopoulos; Georgios I Theocharis; Michalis Petropoulos; Vasileios I Theopistos; Georgia G Diamantopoulou; Zoi Lygerou; Iris Spiliopoulou; Konstantinos C Thomopoulos
Journal:  Dig Dis Sci       Date:  2018-06-07       Impact factor: 3.199

Review 5.  Hepatic encephalopathy.

Authors:  Dieter Häussinger; Radha K Dhiman; Vicente Felipo; Boris Görg; Rajiv Jalan; Gerald Kircheis; Manuela Merli; Sara Montagnese; Manuel Romero-Gomez; Alfons Schnitzler; Simon D Taylor-Robinson; Hendrik Vilstrup
Journal:  Nat Rev Dis Primers       Date:  2022-06-23       Impact factor: 65.038

6.  Hepatic encephalopathy.

Authors:  Peter Ferenci
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-18

Review 7.  Management of bacterial infection in the liver transplant candidate.

Authors:  Alberto Ferrarese; Alberto Zanetto; Chiara Becchetti; Salvatore Stefano Sciarrone; Sarah Shalaby; Giacomo Germani; Martina Gambato; Francesco Paolo Russo; Patrizia Burra; Marco Senzolo
Journal:  World J Hepatol       Date:  2018-02-27

Review 8.  Hepatic encephalopathy: a critical current review.

Authors:  Anna Hadjihambi; Natalia Arias; Mohammed Sheikh; Rajiv Jalan
Journal:  Hepatol Int       Date:  2017-08-02       Impact factor: 6.047

9.  Factors Associated With Short and Long Term Cognitive Changes in Patients With Sepsis.

Authors:  Allan J C Calsavara; Priscila A Costa; Vandack Nobre; Antonio L Teixeira
Journal:  Sci Rep       Date:  2018-03-14       Impact factor: 4.379

10.  Spectrum of bacterial infections and predictors of mortality in adult cirrhotic patients.

Authors:  Chandrashekar Udyavara Kudru; Vandana Kalwaje Eshwara; Shivashankara Kaniyoor Nagiri; Vasudeva Guddattu
Journal:  Med Pharm Rep       Date:  2019-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.